13 Feb 2017
From 20-23 March 2017, MycoSynVac partner ATG:Biosynthetics will be presenting their work on the discovery of new diagnostic and therapeutic epitopes at the 13th German Peptide Symposium at the University of Erlangen-Nürnberg.
Starting from genomic data, PepID technology design libraries of peptides microarrays for epitope discovery and immune surveillance.
They will explain how their approach can help not only on vaccine development but also to identify immunotherapies targets for the treatment of cancer or auto-immune diseases.